SENORES PHARMACEUTICALS L Share Price

Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychloroquine Sulfate Tablets USP, 200 mg; Ketoconazole Tablets USP, 200 mg; Chlorzoxazone Tablets USP, 250 mg; 5Chlorzoxazone Tablets USP, 500 mg; Ketorolac Tromethamine Tablets USP, 10 mg; Diclofenac Potassium Tablets USP, 25 mg; Diclofenac Potassium Tablets USP, 50 mg, and others. It supplies affordable APIs to generic formulations manufacturers. Its product API include Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Azithromycin for Injection; Meropenem Injection; Ferric Carboxymaltose Injection; Meropenem and Sulbactam for Injection, and others.As of 25 May 2026, SENORES PHARMACEUTICALS L share price is ₹1,153.65. The stock opened at ₹1,116.45, compared to its previous close of ₹1,110.95. During today's trading session, SENORES PHARMACEUTICALS L share price moved in the range of ₹1,115.35 to ₹1,160.00, with an average price of ₹1,137.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,115.35 and a high of ₹1,160.00. On the performance front, SENORES PHARMACEUTICALS L share price has increased by 50.73% over the last six months and is up 127.32% on a year-on-year basis.

The market capitalization of SENORES PHARMACEUTICALS L is ₹5,114 Crs, with a P/E ratio of 42.1 and a dividend yield of 0.00%.